AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Herticad 440mg Injection

Prescription Icon
Prescription Required

Marketer

Sayre Therapeutics Pvt Ltd

Salt Composition

Trastuzumab (440mg)

Overview Herticad 440mg Injection

Oncasin 440mg injection combats breast and gastric cancers by targeting and destroying HER2-positive cancer cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's prescribed regimen; improper use or overdose can lead to severe complications. Therapeutic effects might not be immediately apparent, requiring several weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, headache, skin rash, sleep disturbances, and infections. This medication can lower blood cell counts, increasing infection risk. Regular blood tests, including complete blood count, liver function tests, cardiac monitoring, and uric acid levels are essential. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your doctor of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.

Uses of Herticad 440mg Injection

Cancers affecting the breast and stomach.

Major Benefits of Herticad 440mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Herticad 440mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Herticad 440mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Herticad 440mg Injection works:

The injectable medication Herticad 440mg is a monoclonal antibody (IgG1 subtype, recombinant). This therapy targets HER2, a human epidermal growth factor receptor protein overexpressed in breast and gastric cancers, thereby suppressing cancerous cell growth. Herticad achieves this by directly blocking HER2 activity and disrupting multiple downstream signaling pathways crucial for tumor development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Herticad 440mg Injection and alcohol may result in significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Herticad 440mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Herticad 440mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Herticad 440mg Injection's effect on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Herticad 440mg Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Herticad 440mg Injection to individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Herticad 440mg Injection :

Omit a Herticad 440mg Injection dose? Seek your physician's advice.

Facts to Know About Herticad 440mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Type of Treatment Cancer Medications
Action Class Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Herticad 440mg Injection

Herticad 440mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, unusual bruising or bleeding, stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea, vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Contact your doctor immediately if you experience any of these symptoms.
Effective contraception must be used by women of childbearing age throughout Herticad 440mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Herticad 440mg Injection should be administered to patients with early-stage breast cancer for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herticad 440mg Injection does not require fasting beforehand. Administration must be supervised by a qualified oncologist and performed only by a healthcare professional.
Herticad 440mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (SC) injection. Always verify the correct formulation is administered as prescribed. The IV formulation is for intravenous use only; it must not be given subcutaneously. Your doctor may change your treatment between IV and SC Herticad 440mg Injection if medically appropriate.
Herticad 440mg Injection, a monoclonal antibody targeting the HER2 protein, is ineffective in patients with HER2-negative cancer. This medication works by binding to HER2, which is abundant on the surface of some cancer cells, inhibiting their growth and spread. Consequently, it's only beneficial for patients whose cancer cells express HER2 (HER2-positive).
Using Herticad 440mg Injection with anthracyclines (like doxorubicin) can harm your heart. Your doctor must assess your heart health before and during treatment.
Cardiac evaluations are required at treatment initiation, every three months during treatment, and every six months post-treatment for 24 months following the final Herticad 440mg Injection dose. Patients with pre-existing cardiac conditions need evaluations every twelve weeks.
Herticad 440mg Injection
52,686
MRP 61,132
13% off